The FDA stopped inspecting foreign drug factories after the pandemic hit. The move was made to keep inspectors safe from COVID-19, but it also threatens the quality of America’s prescription drug supply.
Three-fourths of the pharmaceuticals sold in the U.S. come from China and India.[1]
In a typical year, the FDA carries out at least 600 foreign drug factory inspections.… Read More